Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (401-410 of 455) with videos related to

Pageof 46
Sort By:
Archives of Gynecology and Obstetrics|April 12, 2020
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study GroupUlrich Canzler, Hans-Joachim Lück, Petra Neuser, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 28, 2023
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7Sabine Heublein, Jacobus Pfisterer, Andreas du Bois, et al.
The Lancet. Oncology|December 8, 2014
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trialAmit M Oza, David Cibula, Ana Oaknin Benzaquen, et al.
Psycho-Oncology|August 2, 2019
Factors associated with the decline of psychological support in hospitalized patients with cancerTheresia Pichler, Andreas Dinkel, Birgitt Marten-Mittag, et al.
Gynecologic Oncology|March 2, 2021
Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 studyKatharina Prieske, Linn Woelber, Mustafa Zelal Muallem, et al.
Cancer Research Communications|March 27, 2023
<i>Ad hoc</i> Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline <i>BRCA</i> Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair DefectsMansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Minimally invasive compared to open surgery in patients with low-risk cervical cancer following simple hysterectomy: An exploratory analysis from the Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trialMarie Plante, Sven Mahner, Alexandra Sebastianelli, et al.
Clinical Breast Cancer|February 14, 2017
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast CancerAmelie Schramm, Fabienne Schochter, Thomas W P Friedl, et al.
Cancers|September 9, 2022
T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell CancerEike Burandt, Niclas C Blessin, Ann-Christin Rolschewski, et al.
The New England Journal of Medicine|February 28, 2024
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical CancerMarie Plante, Janice S Kwon, Sarah Ferguson, et al.
Pageof 46

Showing results (401-410 of 455) with videos related to

Sort By:
Pageof 46
Archives of Gynecology and Obstetrics|April 12, 2020
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study GroupUlrich Canzler, Hans-Joachim Lück, Petra Neuser, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 28, 2023
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7Sabine Heublein, Jacobus Pfisterer, Andreas du Bois, et al.
The Lancet. Oncology|December 8, 2014
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trialAmit M Oza, David Cibula, Ana Oaknin Benzaquen, et al.
Psycho-Oncology|August 2, 2019
Factors associated with the decline of psychological support in hospitalized patients with cancerTheresia Pichler, Andreas Dinkel, Birgitt Marten-Mittag, et al.
Gynecologic Oncology|March 2, 2021
Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 studyKatharina Prieske, Linn Woelber, Mustafa Zelal Muallem, et al.
Cancer Research Communications|March 27, 2023
<i>Ad hoc</i> Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline <i>BRCA</i> Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair DefectsMansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Minimally invasive compared to open surgery in patients with low-risk cervical cancer following simple hysterectomy: An exploratory analysis from the Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trialMarie Plante, Sven Mahner, Alexandra Sebastianelli, et al.
Clinical Breast Cancer|February 14, 2017
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast CancerAmelie Schramm, Fabienne Schochter, Thomas W P Friedl, et al.
Cancers|September 9, 2022
T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell CancerEike Burandt, Niclas C Blessin, Ann-Christin Rolschewski, et al.
The New England Journal of Medicine|February 28, 2024
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical CancerMarie Plante, Janice S Kwon, Sarah Ferguson, et al.
Pageof 46